Skip to main content
SpringerLink
Log in
Book cover

Textbook of Gastrointestinal Oncology pp 445–464Cite as

Imaging in Gastrointestinal Cancers

  • Chapter
  • First Online:

Abstract

This chapter provides a general overview of the common diagnostic imaging findings and optimal use of imaging technologies in the diagnosis, follow-up, and screening of gastrointestinal tract cancers. With the development of state-of-the-art technologies and increased experience with these modalities, imaging is generally the first diagnostic tool employed by physicians in modern medical practice. Imaging modalities such as ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET-CT) can be used in detecting as well as staging of the gastrointestinal cancers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pourhoseingholi MA, Vahedi M, Baghestani AR. Burden of gastrointestinal cancer in asia; an overview. Gastroenterol Hepatol Bed Bench. 2015;8(1):19–27.

    PubMed  PubMed Central  Google Scholar 

  2. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.

    Article  PubMed  Google Scholar 

  3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.

    Article  CAS  PubMed  Google Scholar 

  4. Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, et al. Esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87(4):1048–54; discussion 1054-1045.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008;103(11):2694–9.

    Article  PubMed  Google Scholar 

  6. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6.

    Article  PubMed  Google Scholar 

  7. Fitzgerald RH Jr, Bartles DM, Parker EF. Tracheoesophageal fistulas secondary to carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1981;82(2):194–7.

    PubMed  Google Scholar 

  8. Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer. 1981;48(2):329–35.

    Article  CAS  PubMed  Google Scholar 

  9. Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981;141(2):216–8.

    Article  CAS  PubMed  Google Scholar 

  10. Iyer RB, Silverman PM, Tamm EP, Dunnington JS, DuBrow RA. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181(3):785–93.

    Article  PubMed  Google Scholar 

  11. Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH. Esophageal carcinoma: current concepts in the role of imaging in staging and management. Can Assoc Radiol J. 2015;66(2):130–9.

    Article  PubMed  Google Scholar 

  12. Halvorsen RA Jr, Thompson WM. Ct of esophageal neoplasms. Radiol Clin N Am. 1989;27(4):667–85.

    PubMed  Google Scholar 

  13. Pongpornsup S, Posri S, Totanarungroj K. Diagnostic accuracy of multidetector computed tomography (mdct) in evaluation for mediastinal invasion of esophageal cancer. J Med Assoc Thail. 2012;95(5):704–11.

    Google Scholar 

  14. Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29(2):403–21.

    Article  PubMed  Google Scholar 

  15. Munden RF, Macapinlac HA, Erasmus JJ. Esophageal cancer: the role of integrated ct-pet in initial staging and response assessment after preoperative therapy. J Thorac Imaging. 2006;21(2):137–45.

    Article  PubMed  Google Scholar 

  16. van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, et al. Systematic review of the staging performance of 18f-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22(18):3805–12.

    Article  PubMed  Google Scholar 

  17. Karaosmanoglu AD, Blake MA. Applications of pet-ct in patients with esophageal cancer. Diagn Interv Radiol. 2012;18(2):171–82.

    PubMed  Google Scholar 

  18. Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18f-fdg-pet) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006;243(4):472–8.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, et al. Pet to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the municon phase ii trial. Lancet Oncol. 2007;8(9):797–805.

    Article  PubMed  Google Scholar 

  20. Hallinan JT, Venkatesh SK. Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response. Cancer Imaging. 2013;13:212–27.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63(1):64–71.

    Article  PubMed  Google Scholar 

  22. Parkin DM, Bray FI. Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4–66.

    Article  PubMed  Google Scholar 

  23. Davies J, Chalmers AG, Sue-Ling HM, May J, Miller GV, Martin IG, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut. 1997;41(3):314–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Sheybani A, Menias CO, Luna A, Fowler KJ, Hara AK, Silva AC, et al. Mri of the stomach: a pictorial review with a focus on oncological applications and gastric motility. Abdom Imaging. 2015;40(4):907–30.

    Article  PubMed  Google Scholar 

  25. Malibari N, Hickeson M, Lisbona R. Pet/computed tomography in the diagnosis and staging of gastric cancers. PET Clin. 2015;10(3):311–26.

    Article  PubMed  Google Scholar 

  26. Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. Fdg pet imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging. 2003;30(2):288–95.

    Article  CAS  PubMed  Google Scholar 

  27. Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer. 2005;103(11):2383–90.

    Article  PubMed  Google Scholar 

  28. Yeung HW, Macapinlac H, Karpeh M, Finn RD, Larson SM. Accuracy of fdg-pet in gastric cancer. Preliminary experience. Clin Positron Imaging. 1998;1(4):213–21.

    Article  PubMed  Google Scholar 

  29. Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallbohmer D, et al. Variable 18f-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of glut-1 expression. Nucl Med Commun. 2010;31(6):532–8.

    CAS  PubMed  Google Scholar 

  30. Berger KL, Nicholson SA, Dehdashti F, Siegel BA. Fdg pet evaluation of mucinous neoplasms: correlation of fdg uptake with histopathologic features. AJR Am J Roentgenol. 2000;174(4):1005–8.

    Article  CAS  PubMed  Google Scholar 

  31. Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys. 1990;19(6):1357–62.

    Article  CAS  PubMed  Google Scholar 

  32. Lehnert T, Rudek B, Buhl K, Golling M. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol. 2002;28(4):455–61.

    Article  CAS  PubMed  Google Scholar 

  33. Roukos DH. Extended (d2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol. 2000;7(4):253–5.

    Article  CAS  PubMed  Google Scholar 

  34. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with fdg pet imaging: physiologic and benign variants. Radiographics. 1999;19(1):61–77; quiz 150-151.

    Article  CAS  PubMed  Google Scholar 

  35. Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29(2):347–73.

    Article  PubMed  Google Scholar 

  36. Low RN. Mr imaging of the peritoneal spread of malignancy. Abdom Imaging. 2007;32(3):267–83.

    Article  PubMed  Google Scholar 

  37. Vicens RA, Patnana M, Le O, Bhosale PR, Sagebiel TL, Menias CO, et al. Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists. Abdom Imaging. 2015;40(2):436–56.

    Article  PubMed  Google Scholar 

  38. Park CM, Kim SH, Kim SH, Moon MH, Kim KW, Choi HJ. Recurrent ovarian malignancy: patterns and spectrum of imaging findings. Abdom Imaging. 2003;28(3):404–15.

    Article  CAS  PubMed  Google Scholar 

  39. Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR. Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with ct. Radiographics. 1992;12(6):1051–68.

    Article  CAS  PubMed  Google Scholar 

  40. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993;72(5):1631–6.

    Article  CAS  PubMed  Google Scholar 

  41. Walkey MM, Friedman AC, Sohotra P, Radecki PD. Ct manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol. 1988;150(5):1035–41.

    Article  CAS  PubMed  Google Scholar 

  42. Whitley NO, Bohlman ME, Baker LP. Ct patterns of mesenteric disease. J Comput Assist Tomogr. 1982;6(3):490–6.

    Article  CAS  PubMed  Google Scholar 

  43. De Gaetano AM, Calcagni ML, Rufini V, Valenza V, Giordano A, Bonomo L. Imaging of peritoneal carcinomatosis with fdg pet-ct: diagnostic patterns, case examples and pitfalls. Abdom Imaging. 2009;34(3):391–402.

    Article  PubMed  Google Scholar 

  44. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)f-fdg pet. J Nucl Med. 2003;44(9):1407–12.

    PubMed  Google Scholar 

  45. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.

    Article  PubMed  Google Scholar 

  46. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63–71.

    Article  PubMed  Google Scholar 

  47. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16(7):781–7.

    Article  PubMed  Google Scholar 

  48. Reynolds I, Healy P, McNamara DA. Malignant tumours of the small intestine. Surgeon. 2014;12(5):263–70.

    Article  PubMed  Google Scholar 

  49. Kadakia SC, Parker A, Canales L. Metastatic tumors to the upper gastrointestinal tract: endoscopic experience. Am J Gastroenterol. 1992;87(10):1418–23.

    CAS  PubMed  Google Scholar 

  50. Algin O, Evrimler S, Arslan H. Advances in radiologic evaluation of small bowel diseases. J Comput Assist Tomogr. 2013;37(6):862–71.

    Article  PubMed  Google Scholar 

  51. Horton KM, Juluru K, Montogomery E, Fishman EK. Computed tomography imaging of gastrointestinal stromal tumors with pathology correlation. J Comput Assist Tomogr. 2004;28(6):811–7.

    Article  PubMed  Google Scholar 

  52. Druce M, Rockall A, Grossman AB. Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol. 2009;5(5):276–83.

    Article  PubMed  Google Scholar 

  53. Masselli G, Gualdi G. Mr imaging of the small bowel. Radiology. 2012;264(2):333–48.

    Article  PubMed  Google Scholar 

  54. Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of mr enteroclysis with mr enterography and conventional enteroclysis in patients with crohn's disease. Eur Radiol. 2008;18(3):438–47.

    Article  PubMed  Google Scholar 

  55. Das CJ, Manchanda S, Panda A, Sharma A, Gupta AK. Recent advances in imaging of small and large bowel. PET Clin. 2016;11(1):21–37.

    Article  PubMed  Google Scholar 

  56. Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R. Malignant tumours of the small intestine: a review of histopathology, multidetector ct and mri aspects. Br J Radiol. 2011;84(1004):677–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Tan EH, Tan CH. Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol. 2011;2(1):28–43.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Maxwell JE, Howe JR. Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol. 2015;2(2):159–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Sundin A. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol [Review]. 2012;26(6):803–18.

    Article  Google Scholar 

  60. Jain TK, Karunanithi S, Dhull VS, Roy SG, Kumar R. Carcinoma of unknown primary of neuroendocrine origin: accurate detection of primary with (68)ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-nai3-octreotide positron emission tomography/computed tomography enterography. Indian J Nucl Med. 2014;29(2):122–3.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Krausz Y, Freedman N, Rubinstein R, Lavie E, Orevi M, Tshori S, et al. 68ga-dota-noc pet/ct imaging of neuroendocrine tumors: comparison with (1)(1)(1)in-dtpa-octreotide (octreoscan(r)). Mol Imaging Biol [Clinical Trial Comparative Study]. 2011;13(3):583–93.

    Article  Google Scholar 

  62. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502.

    Article  PubMed  Google Scholar 

  63. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.

    Article  PubMed  Google Scholar 

  64. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894–9.

    Article  CAS  PubMed  Google Scholar 

  65. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996–9.

    Article  CAS  PubMed  Google Scholar 

  66. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.

    Article  CAS  PubMed  Google Scholar 

  67. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, et al. Mr imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012;32(2):389–409.

    Article  PubMed  Google Scholar 

  68. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc. 1989;3(2):96–9.

    Article  CAS  PubMed  Google Scholar 

  69. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution mr imaging with histopathologic comparison. Radiology. 2003;227(2):371–7.

    Article  PubMed  Google Scholar 

  70. Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum. 1990;33(7):598–601.

    Article  CAS  PubMed  Google Scholar 

  71. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.

    Article  CAS  PubMed  Google Scholar 

  72. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251–70.

    Article  CAS  PubMed  Google Scholar 

  73. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.

    Article  CAS  PubMed  Google Scholar 

  74. Levine MS, Yee J. History, evolution, and current status of radiologic imaging tests for colorectal cancer screening. Radiology. 2014;273(2 Suppl):S160–80.

    Article  PubMed  Google Scholar 

  75. Baker ME, Bogoni L, Obuchowski NA, Dass C, Kendzierski RM, Remer EM, et al. Computer-aided detection of colorectal polyps: can it improve sensitivity of less-experienced readers? Preliminary findings. Radiology. 2007;245(1):140–9.

    Article  PubMed  Google Scholar 

  76. Dachman AH, Obuchowski NA, Hoffmeister JW, Hinshaw JL, Frew MI, Winter TC, et al. Effect of computer-aided detection for ct colonography in a multireader, multicase trial. Radiology. 2010;256(3):827–35.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Petrick N, Haider M, Summers RM, Yeshwant SC, Brown L, Iuliano EM, et al. Ct colonography with computer-aided detection as a second reader: observer performance study. Radiology. 2008;246(1):148–56.

    Article  PubMed  Google Scholar 

  78. Regge D, Della Monica P, Galatola G, Laudi C, Zambon A, Correale L, et al. Efficacy of computer-aided detection as a second reader for 6-9-mm lesions at ct colonography: Multicenter prospective trial. Radiology. 2013;266(1):168–76.

    Article  PubMed  Google Scholar 

  79. Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. Ct colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357(14):1403–12.

    Article  CAS  PubMed  Google Scholar 

  80. Kim DH, Pooler BD, Weiss JM, Pickhardt PJ. Five year colorectal cancer outcomes in a large negative ct colonography screening cohort. Eur Radiol. 2012;22(7):1488–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Hacettepe University, School of Medicine, Sıhhiye, Ankara, Turkey

    Ali Devrim Karaosmanoglu & Mehmet Ruhi Onur

  2. Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA

    Ronald S. Arellano

Authors
  1. Ali Devrim Karaosmanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Ruhi Onur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald S. Arellano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, Hacettepe University Institute of Cancer, Sihhiye, Ankara, Turkey

    Suayib Yalcin

  2. Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA

    Philip A. Philip

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Karaosmanoglu, A.D., Onur, M.R., Arellano, R.S. (2019). Imaging in Gastrointestinal Cancers. In: Yalcin, S., Philip, P. (eds) Textbook of Gastrointestinal Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-18890-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18890-0_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18888-7

  • Online ISBN: 978-3-030-18890-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation